HLA-B*5701 Genotyping for Abacavir Prescription: Re-Examination of its Cost-Effectiveness in Singapore

被引：0
|
作者：
Goh, Kang Shiong [1 ]
Kapoor, Ritika [2 ]
Lee, Cheng Chuan [3 ]
Ng, Carol Y. L. [4 ]
Leong, Khai Pang [3 ]
机构：
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[2] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[3] Tan Tock Seng Hosp, Dept Rheumatol Allergy & Immunol, Singapore, Singapore
[4] Tan Tock Seng Hosp, Clin Immunol Lab, Singapore, Singapore
来源：
ANNALS ACADEMY OF MEDICINE SINGAPORE | 2019年 / 48卷 / 04期
关键词：
HYPERSENSITIVITY REACTIONS; HIV;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：133 / 138
页数：6
相关论文
共 46 条
  • [41] HLA-B*1502 haplotype screening prior to carbamazepine administration in southeast-Asian ethnic groups near cost-effectiveness in preventing severe cutaneous adverse drug reactions
    Kim, E.
    McCrossin, I.
    Frew, J.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 77 - 77
  • [42] Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand
    Kategeaw, Warittakorn
    Nakkam, Nontaya
    Kiertiburanakul, Sasisopin
    Sukasem, Chonlaphat
    Tassaneeyakul, Wichittra
    Chaiyakunapruk, Nathorn
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1330 - 1341
  • [43] HLA-B*1502 haplotype screening prior to carbamazepine administration in individuals of south-east Asian ancestry nears cost-effectiveness in preventing severe cutaneous adverse drug reactions
    Kim, Emma
    McCrossin, Ian
    Frew, John W.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 (03) : 245 - 246
  • [44] COST-EFFECTIVENESS ANALYSIS OF HLA-B*5801 GENETIC TESTING PRIOR TO INITIATION OF ALLOPURINOL THERAPY TO PREVENT ALLOPURINOL-INDUCED STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN MALAYSIAN POPULATION
    Chong, H. Y.
    Lim, Y. H.
    Prawjaeng, J.
    Chaiyakunapruk, N.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A6 - A6
  • [45] Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population
    Chong, Huey Yi
    Lim, Yi Heng
    Prawjaeng, Juthamas
    Tassaneeyakul, Wichittra
    Mohamed, Zahurin
    Chaiyakunapruk, Nathorn
    [J]. PHARMACOGENETICS AND GENOMICS, 2018, 28 (02): : 56 - 67
  • [46] UNFAVORABLE OUTCOMES ASSOCIATED WITH GENETIC SCREENING OF HLA-B*13:01 FOR THE PREVENTION OF CO-TRIMOXAZOLE-INDUCED SEVERE CUTANEOUS ADVERSE REACTIONS AMONG HIV-INFECTED PATIENTS IN THAILAND: A COST-EFFECTIVENESS ANALYSIS
    Kategeaw, W.
    Nakkam, N.
    Kiertiburanakul, S.
    Sukasem, C.
    Tassaneeyakul, W.
    Chaiyakunapruk, N.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S119 - S119
12345